Rejuvenation Technologies
Biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres
Rejuvenation Technologies aims to reverse aging by extending the protective cap of DNA that functions as an aging clock, called telomeres.
Extending telomeres to extend the human healthspan. We have a robust pipeline focused on aging and fatal diseases in which short telomeres have causal or major exacerbating roles. We are developing these programs in-house and through partnerships and out-licensing.
Visit website: https://rejuvenationtech.com/
Details last updated 28-May-2022
People at Rejuvenation Technologies
Rejuvenation Technologies News
Rejuvenation Technologies raises $10.6M to develop anti-ageing therapies
Longevity Technology - 07-Sep-2023
A single dose of mRNA therapy could rewind ageing and extend lifespan
Read more...